Shopping Cart
- Remove All
Your shopping cart is currently empty
RLY-2608 is a selective mutant PI3Kα inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $538 | In Stock | |
| 5 mg | $1,070 | In Stock | |
| 10 mg | $1,730 | In Stock | |
| 25 mg | $2,580 | In Stock | |
| 50 mg | $3,480 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $1,430 | In Stock |
| Description | RLY-2608 is a selective mutant PI3Kα inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model. |
| Targets&IC50 | PI3Kα:4 nM |
| Synonyms | Zovegalisib, RLY2608, RLY 2608 |
| Molecular Weight | 608.91 |
| Formula | C29H14ClF5N6O2 |
| Cas No. | 2733573-94-7 |
| Smiles | N(C(=O)C1=CC(C(F)(F)F)=CC(F)=C1)C2=C3[C@@H](NC(=O)C3=CC(=C2)C4=C(C#N)N5C(C=C4)=NC=N5)C6=C(Cl)C=CC(F)=C6 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (131.38 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.